Skip to main content
. Author manuscript; available in PMC: 2020 May 18.
Published in final edited form as: Bioconjug Chem. 2018 Oct 24;29(12):3937–3966. doi: 10.1021/acs.bioconjchem.8b00548

Figure 5. Passive immunotherapy strategies for antibodies recognizing lymphocyte antigens.

Figure 5.

Antibodies that recognize molecules expressed by malignant infiltrating lymphocytes may be used to treat certain CNS lymphomas. Adapted from: 74,78.